Ashwini Mallappa

1.4k total citations
45 papers, 938 citations indexed

About

Ashwini Mallappa is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Ashwini Mallappa has authored 45 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 35 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Ashwini Mallappa's work include Sexual Differentiation and Disorders (38 papers), Adrenal Hormones and Disorders (21 papers) and Hormonal and reproductive studies (18 papers). Ashwini Mallappa is often cited by papers focused on Sexual Differentiation and Disorders (38 papers), Adrenal Hormones and Disorders (21 papers) and Hormonal and reproductive studies (18 papers). Ashwini Mallappa collaborates with scholars based in United States, United Kingdom and Germany. Ashwini Mallappa's co-authors include Deborah P. Merke, Ninet Sinaii, Richard Ross, Diala El‐Maouche, Parag Kumar, Wiebke Arlt, Aikaterini A. Nella, Steven D. Chernausek, Jeanie B. Tryggestad and Meredith Elman and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Ashwini Mallappa

39 papers receiving 926 citations

Peers

Ashwini Mallappa
Ashwini Mallappa
Citations per year, relative to Ashwini Mallappa Ashwini Mallappa (= 1×) peers Ingrid Nermoen

Countries citing papers authored by Ashwini Mallappa

Since Specialization
Citations

This map shows the geographic impact of Ashwini Mallappa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwini Mallappa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwini Mallappa more than expected).

Fields of papers citing papers by Ashwini Mallappa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwini Mallappa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwini Mallappa. The network helps show where Ashwini Mallappa may publish in the future.

Co-authorship network of co-authors of Ashwini Mallappa

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwini Mallappa. A scholar is included among the top collaborators of Ashwini Mallappa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwini Mallappa. Ashwini Mallappa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Marko, Jamie, et al.. (2025). Longitudinal Characterization and Sonographic Staging of Testicular Adrenal Rest Tumors. The Journal of Clinical Endocrinology & Metabolism. 111(3). 698–706.
3.
Cunha, Isabela Werneck da, James Iben, Sun A. Kim, et al.. (2024). Evidence of the Role of Inflammation and the Hormonal Environment in the Pathogenesis of Adrenal Myelolipomas in Congenital Adrenal Hyperplasia. International Journal of Molecular Sciences. 25(5). 2543–2543.
5.
Reisch, Nicole, Wiebke Arlt, Aude Brac de la Perrière, et al.. (2023). Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia. European Journal of Endocrinology. 188(1). 109–117. 7 indexed citations
6.
Iqbal, Nayyar, Phil Ambery, Jennifer Logue, Ashwini Mallappa, & C. David Sjöström. (2023). Perspectives in weight control in diabetes – SGLT2 inhibitors and GLP-1–glucagon dual agonism. Diabetes Research and Clinical Practice. 199. 110669–110669. 9 indexed citations
7.
Mallappa, Ashwini & Deborah P. Merke. (2022). Management challenges and therapeutic advances in congenital adrenal hyperplasia. Nature Reviews Endocrinology. 18(6). 337–352. 55 indexed citations
8.
Cunha, Isabela Werneck da, James Iben, Ashwini Mallappa, et al.. (2021). Morphologic and Molecular Characterization of Adrenals and Adrenal Rest Affected by Congenital Adrenal Hyperplasia. Frontiers in Endocrinology. 12. 730947–730947. 10 indexed citations
9.
Lao, Qizong, et al.. (2020). A TNXB splice donor site variant as a cause of hypermobility type Ehlers–Danlos syndrome in patients with congenital adrenal hyperplasia. Molecular Genetics & Genomic Medicine. 9(2). e1556–e1556. 9 indexed citations
10.
El‐Maouche, Diala, et al.. (2019). Adrenal morphology and associated comorbidities in congenital adrenal hyperplasia. Clinical Endocrinology. 91(2). 247–255. 14 indexed citations
11.
Jha, Smita, et al.. (2019). Individualizing Management of Infertility in Classic Congenital Adrenal Hyperplasia and Testicular Adrenal Rest Tumors. Journal of the Endocrine Society. 3(12). 2290–2294. 9 indexed citations
12.
Krishnan, Sowmya, et al.. (2017). Management Challenges in a Child with Chronic Hyponatremia: Use of V2 Receptor Antagonist. SHILAP Revista de lepidopterología. 2017(1). 3757423–3757423.
13.
Han, Thang S., Ashwini Mallappa, Meredith Elman, et al.. (2016). Androgens correlate with increased erythropoiesis in women with congenital adrenal hyperplasia. Clinical Endocrinology. 86(1). 19–25. 19 indexed citations
14.
Jones, Christopher M., Ashwini Mallappa, Nicole Reisch, et al.. (2016). Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 102(6). jc.2016–2855. 43 indexed citations
15.
Mallappa, Ashwini, et al.. (2016). Positive fertility outcomes in a female with classic congenital adrenal hyperplasia following bilateral adrenalectomy. International Journal of Pediatric Endocrinology. 2016(1). 10–10. 7 indexed citations
16.
Mallappa, Ashwini & Miguel Debono. (2015). Recent Advances in Hydrocortisone Replacement Treatment. Endocrine development. 30. 42–53. 16 indexed citations
17.
Morissette, Rachel, Wuyan Chen, Jennifer L. Dreiling, et al.. (2015). Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 100(8). E1143–E1152. 47 indexed citations
18.
Debono, Miguel, Ashwini Mallappa, Verena Gounden, et al.. (2015). Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers. European Journal of Endocrinology. 173(6). 727–737. 34 indexed citations
19.
Mallappa, Ashwini, et al.. (2014). A Descriptive study to assess the knowledge and practice regarding toilet training among the mothers of early childhood (17 to 30 months) children in selected rural area at Tumkur district, Karnataka. International Journal of Nursing Education and Research. 2(2). 180–185.
20.
Mallappa, Ashwini, Ninet Sinaii, Parag Kumar, et al.. (2014). A Phase 2 Study of Chronocort, a Modified-Release Formulation of Hydrocortisone, in the Treatment of Adults With Classic Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 100(3). 1137–1145. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026